Study Comparing Tigecycline to Imipenem/Cilastatin in Complicated Intra-Abdominal Infections in Hospitalized Subjects

NCT00081744 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

850

Enrollment

INDUSTRY

Sponsor class

Conditions

Gram-Positive Bacterial Infections
Cross Infection

Interventions

DRUG: Tigecycline

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer